Loading company…
Proteon Therapeutics develops treatments for bladder cancer, lymphatic malformations, and choline deficiency.
Founded in 2001 and based in Waltham, US, Proteon Therapeutics develops TARA-002, an investigational cell therapy, and IV Choline Chloride. The treatments are aimed at healthcare providers and institutions, with TARA-002 approved for use in Japan and Taiwan. The company raised USD 61.1 million in its IPO on October 21, 2014.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in